Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Prenatally androgenized ewes can model increased hair diameter in women with PCOS.

Manage women's cholesterol with diet, exercise, and careful treatment choices, especially during pregnancy, PCOS, and menopause.

Scalp hair thinning in women with PCOS is linked to metabolic issues like abnormal glucose tolerance, high LDL, and skipped meals.

Clinicians can use vibe coding to easily engage in machine learning research without needing to know Python.

Non-invasive imaging helped diagnose a woman's severe hormone imbalance and diabetes, and medication successfully treated her condition.

A postmenopausal woman's excessive hair growth and hair loss were due to a non-cancerous ovarian condition, treated successfully with surgery.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Androgens can cause hair growth in some areas and hair loss on the scalp.

Cyproterone acetate is effective for treating hirsutism, but some patients may feel worse on low-dose maintenance therapy.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Antiandrogens are somewhat effective in reducing excessive hair growth in women.

Insulin sensitizers may slightly reduce hirsutism but are less effective than other treatments.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

Hair loss in young men linked to higher risk of insulin resistance and metabolic issues.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Women with PCOS have higher 5α-reductase activity, which may be linked to insulin resistance.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

Hormones significantly affect skin health, with vitamin D playing a key role.

Most women referred for excess male hormone symptoms had polycystic ovary syndrome (PCOS), with other conditions being less common.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Women with PCOS have a higher risk of diabetes and heart problems, especially when they get older.

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

The research suggests that the global distribution of PCOS is likely due to historical human migration and that genes affecting PCOS may have different impacts on males and females.

Women with PCOS often have mood disorders and a lower quality of life, and treatment should focus on both physical and mental health.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.